by Elizabeth Pisani
Review on Antimicrobial Resistance, September 22, 2015
The paper found that sloppily made medicines churned out by low-cost producers for markets where oversight is low probably contribute far more to antimicrobial resistance world-wide than out-and-out fakes. The paper proposes a number of actions including better surveillance of medicine quality along the lines developed for tracking bad malaria drugs, and a radical expansion of the WHO’s medicine pre-qualification system. In addition, governments in the countries that make most low-cost drugs, notably India, should be incentivised to do more to secure the quality of the drugs they export.